Stolarczyk Jędrzej, Kubiś Marek, Brzosko Marek
Pomeranian J Life Sci. 2016;62(1):35-9.
There have been many cases of the appearance of autoantibodies and symptoms of disease after exposure to adjuvants, not only after breast augmentation with silicone implants, but also as a very rare vaccination side effect, such as Gulf war syndrome or macrophagic myofasciitis syndrome. Diseases whose symptoms developed after such adjuvant exposure are called autoimmune/ inlammatory syndrome induced by adjuvants (ASIA). The group of adjuvants includes not only silicone implants, silica, squalen and aluminium, but also ink components used for making tattoos. Analyzing the available reports on the inluence of adjuvants on the development of autoimmune diseases, the conclusion is that apart from long -term silicone exposure, the coexistence of other factors such as genetic or environmental is also necessary. Metaanalyses clearly do not conirm an increased risk of developing autoimmune disease after breast augmentation with silicone implants, or tattooing, but it seems that among these patients there is a group that is more predestined to develop disease symptoms. In the general population the beneits of vaccination are obvious, and the risk of severe adverse events following immunisation is incomparably lower than the risk of developing a speciic disease and its complications, also for patients with diagnosed autoimmune diseases. Because of data heterogeneity in previous studies and dificulties in diagnosing ASIA it seems necessary to conduct further analyses of adjuvants’ inluence on autoimmune disease development, and to reine ASIA diagnostic criteria, which now allow too easy a diagnosis of this syndrome.
接触佐剂后出现自身抗体和疾病症状的情况屡见不鲜,不仅在使用硅胶植入物隆胸后会出现,而且作为一种极为罕见的疫苗接种副作用也会出现,如海湾战争综合征或巨噬细胞性肌筋膜炎综合征。在接触此类佐剂后出现症状的疾病被称为佐剂诱导的自身免疫/炎症综合征(ASIA)。佐剂不仅包括硅胶植入物、二氧化硅、角鲨烯和铝,还包括纹身所用的墨水成分。分析关于佐剂对自身免疫性疾病发展影响的现有报告后得出的结论是,除了长期接触硅胶外,遗传或环境等其他因素的共存也是必要的。荟萃分析显然并未证实使用硅胶植入物隆胸或纹身后患自身免疫性疾病的风险增加,但似乎在这些患者中有一部分人更易出现疾病症状。在普通人群中,疫苗接种的益处显而易见,免疫接种后发生严重不良事件的风险远低于患特定疾病及其并发症的风险,对于已确诊自身免疫性疾病的患者也是如此。由于先前研究中的数据存在异质性,且ASIA的诊断存在困难,似乎有必要进一步分析佐剂对自身免疫性疾病发展的影响,并完善ASIA的诊断标准,目前该综合征的诊断过于容易。